Michael Forer
Partner
Michael Forer was a co-founder of Rosetta in 2001. Michael has more than 20 years’ experience in the life science sector as an entrepreneur, advisor and investor, initially at Rothschild Asset Management. As a partner at Auven Therapeutics, he led the investment in Spirogen (sold to AstraZeneca) and the spin-out of ADC Therapeutics. Michael holds a BA in economics, and a diploma in international business. Michael gained an LLB from the University of British Columbia before articling at the predecessor law firm of Norton Rose Canada.
Michael has held key Board roles in Rosetta portfolio companies including Aditech, KDev Investments, Resonant Medical and Rose Pharma.
Meet more of our people